Exclusive
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Unicorn India Ventures Invests INR 3 Cr in Biotech Startup Exsure

Written by : Dr. Aishwarya Sarthe

January 23, 2025

Category Img

The investment will enable Exsure to complete its non-clinical studies and present the data to the CDSCO by the end of the year.

Unicorn India Ventures, a prominent venture capitalist firm, has pledged INR 3 Cr in funding for Bhubaneswar-based biotech startup Exsure.

The investment will enable Exsure to complete its non-clinical studies and present data to the Central Drugs Standard Control Organization (CDSCO) by the end of the year.

Exsure, founded in 2021, is developing a patented exosomal drug-delivery platform to reduce the toxicity and side effects of anti-cancer drugs.

Over the past year, the startup has been conducting non-clinical studies in collaboration with a contract research organization (CRO) and recently met one of its preclinical objectives.

Exsure's exosomal drug-delivery platform targets both cancer cells and cancer stem cells, aiming to address significant gaps in oncology treatment. The startup seeks to minimize the adverse effects often associated with anti-cancer therapies, providing a potentially safer alternative for patients.

Bhaskar Majumdar, Managing Partner at Unicorn India Ventures, said, “The funding accelerates Exsure’s mission to deploy solutions at a global level. We believe Exsure will sustain its momentum and achieve significant growth due to its potential for transformative breakthroughs through its nano delivery platform.”

Exsure is strategically positioned within the rapidly growing Indian biotech sector, projected to reach $150 billion by the end of 2025 and expand further to $270–$300 billion by 2030. The startup plans to use the recent funding to enhance its team and strengthen its global marketing and sales efforts.


More from this Author

POPULAR CATEGORIES

WEEKLY POPULAR POSTS

ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2025